![]() |
|
|
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Department of Pharmacy, Kyoto University Hospital, Faculty of Medicine, Kyoto University, Sakyo-ku, Kyoto, Japan
Received November 22, 2006; accepted February 27, 2007
| Abstract |
|---|
|
|
|---|
3) have been identified and characterized (Burckhardt and Wolff, 2000
In contrast to OCTs, the molecular nature of H+/organic cation antiport system has not been characterized, but recently, orthologs of the multidrug and toxin extrusion (MATE) family have been identified in various species (Otsuka et al., 2005a
; Hiasa et al., 2006
; Masuda et al., 2006
; Terada et al., 2006
). We have cloned rat (r)MATE1 cDNA and demonstrated that rMATE1 mRNA is mainly expressed in the kidney (proximal convoluted and straight tubules), and rMATE1 can transport not only organic cations such as tetraethylammonium (TEA), cimetidine, and metformin but also the zwitterionic compound cephalexin (Terada et al., 2006
). Furthermore, we revealed recently that an oppositely directed H+ gradient serves as a driving force for the transport of TEA via rMATE1 (Tsuda et al., 2007
). We also cloned human (h)MATE2-K cDNA and revealed that hMATE2-K and the hMATE1 was localized at the brush-border membranes of renal proximal tubules (Masuda et al., 2006
). hMATE2-K can also transport organic cations such as TEA, procainamide, metformin, and creatinine and works as an H+/organic cation antiporter (Masuda et al., 2006
). These studies suggested that the mammalian MATE family showed similar characteristics to the renal H+/organic cation antiport system (Inui and Okuda, 1998
; Wright, 2005
). During the course of studying the transport of TEA using rat renal brush-border membrane vesicles, we found that treatment of membrane vesicles with sulfhydryl reagents such as p-chloromercuribenzenesulfonate (PCMBS) (Hori et al., 1987
) and the histidine residue modifier diethyl pyrocarbonate (DEPC) (Hori et al., 1989
) significantly inhibited [14C]TEA transport by H+/organic cation antiport system. Furthermore, very recently, Ohta et al. (2006
) demonstrated that PCMBS inhibited the uptake of TEA by rMATE1. Based on these findings, it was speculated that histidine and cysteine residues play important roles in the transport activity of MATE family. The present study was undertaken to identify the essential histidine and cysteine residues of the MATE family (especially rMATE1) using site-directed mutagenesis and to examine their functional roles using chemical modifiers.
| Materials and Methods |
|---|
|
|
|---|
Plasmids and Site-Directed Mutagenesis. The rMATE1 cDNA was excised from rMATE1/pcDNA3.1 (Terada et al., 2006
), and was subcloned into pFLAG-CMV-6 (Sigma) to yield FLAG-rMATE1. The site-directed mutations of histidine or cysteine residues were introduced into FLAG-rMATE1, hMATE1/pcDNA3.1 (Yonezawa et al., 2006
), or hMATE2-K/pcDNA3.1 (Masuda et al., 2006
) with a QuikChange II site-directed mutagenesis kit (Stratagene, La Jolla, CA) with the primers listed in Supplemental Table S1. The nucleotide sequences of these constructs were confirmed using multicapillary DNA sequencer RISA384 system (Shimadzu, Kyoto, Japan).
Cell Culture, Transfection, and Transport Measurements. HEK293 cells (CRL-1573; American Type Culture Collection, Manassas, VA) were cultured as described previously (Urakami et al., 2002
; Terada et al., 2006
). Various constructs were transfected into HEK293 cells using LipofectAMINE 2000 Reagent (Invitrogen, Carlsbad, CA) according to the manufacturer's instructions. At 48 h after the transfection, the cells were used for uptake experiments. Cellular uptake of [14C]TEA was measured with monolayers grown on poly(D-lysine)-coated 24-well plates. To manipulate the intracellular pH, intracellular acidification was performed by pretreatment with ammonium chloride (30 mM, 20 min at 37°C, pH 7.4) (Masuda et al., 2006
; Terada et al., 2006
). The medium was then removed, and 0.2 ml of incubation medium, pH 7.4, containing [14C]TEA was added. The medium was aspirated off at the end of the incubation, and monolayers were rapidly rinsed twice with 1 ml of ice-cold incubation medium. The cells were solubilized in 0.5 ml of 0.5 N NaOH, and then the radioactivity in aliquots was determined by liquid scintillation counting. The protein content of the solubilized cells was determined using a Bio-Rad Protein Assay Kit (Bio-Rad Laboratories, Hercules, CA) with bovine
-globulin as a standard.
|
Cell Surface Biotinylation. Cell surface biotinylation was performed according to the methods of Hong et al. (2004
) with some modification. HEK293 cells were grown on poly(D-lysine)-coated six-well plates and transfected with the rMATE1cDNAs. At 48 h after the transfection, cells were washed with ice-cold phosphate-buffered saline calcium/magnesium (138 mM NaCl, 2.7 mM KCl, 1.5 mM KH2PO4, 9.6 mM Na2HPO4, 1 mM MgCl2, and 0.1 mM CaCl2, pH 7.3) and then treated with 1 ml of membrane-impermeable biotinylating agent, sulfo-NHS-SS-biotin (Pierce, Rockford, IL) (1.5 mg/ml) at 4°C for 1 h. Subsequently, the cells were washed three times with ice-cold phosphate-buffered saline calcium/magnesium containing 100 mM glycine and then incubated for 20 min at 4°C with the same buffer to remove the remaining labeling agent. After washing with phosphate-buffered saline calcium/magnesium, cells were disrupted with 700 µl of lysis buffer (10 mM Tris-base, 150 mM NaCl, 1 mM EDTA, 0.1% SDS, and 1% Triton X-100, pH 7.4) containing protease inhibitors at 4°C for 1 h with constant agitation. After centrifugation, 140 µl of streptavidin agarose beads (Pierce) were added to 600 µl of cell lysate and incubated for 1 h at room temperature to isolate the plasma membrane protein.
Western Blot Analysis. The procedures for Western blot analysis were described previously (Terada et al., 1996
). Monoclonal anti-FLAG-M2 antibody (1:4000 dilution; Sigma) or Na+/K+-ATPase antibody (1:2000 dilution; Upstate Biotechnology, Lake Placid, NY) was used as the primary antibody. A peroxidase-conjugated anti-mouse IgG antibody was used for detection of bound antibodies, and strips of the blots were visualized by chemiluminescence on X-ray film.
Immunofluorescence of Transfected Cells. HEK293 cells were seeded onto poly(D-lysine)-coated cover glasses (BD Biosciences, San Jose, CA), and then transfection was performed. Cells were washed twice in Tris-buffered saline (TBS), fixed for 1 min at room temperature in a mixture of methanol/acetone (1:1), and re-washed in TBS. The cells were incubated for 1 h at room temperature in TBS containing monoclonal anti-FLAG M2-FITC antibody (Sigma) (1:1000). Cells were thoroughly washed, and coverslips were mounted. These samples were examined with Eclipse E800 fluorescence microscope (Nikon, Tokyo, Japan) equipped with MRC-1024 laser confocal system (Bio-Rad Laboratories).
Statistical Analysis. The significance of differences between the wild-type and mutant were analyzed using Dunnett's post hoc analysis. Two or three experiments were conducted, and representative results are shown. Other analyses were conducted with Student's t test.
| Results |
|---|
|
|
|---|
|
|
|
Protein Expression of rMATE1 Mutants. One possible reason for the defective transport activity of these mutants is a decreased level of the mutant protein in the plasma membranes of HEK293 cells, which could be caused by reduced stability and/or impaired insertion into the membranes of the mutants. To examine this possibility, Western blot analyses of plasma membranes prepared from each rMATE1 mutant and the immunolocalization of rMATE1 mutants were performed. Cell surface biotinylation was performed to specifically capture plasma membranes, and biotinylation techniques were confirmed to detect Na+/K+-ATPase for all samples (Goel et al., 2005
). As shown in Fig. 5, all MATE1 mutant proteins were expressed at plasma membranes and wild-type MATE1. Furthermore, immunofluorescence analyses with confocal microscopy revealed that the rMATE1 mutant proteins with H385Q, C62G, and C126G were localized at the plasma membranes (Fig. 6). Although intracellular staining in addition to membrane labeling was observed, this might be caused by the overexpression of rMATE1. This issue of expression pattern could not be ruled out in the transient expression system. These findings suggested that the low levels of transport activity of rMATE1 mutants with H385G, C62G, and C126G were not caused by the alteration of protein expression in plasma membranes.
|
|
Effects of DEPC or PCMBS Treatment on rMATE1 Function. We next examined the functional roles of the cysteine and histidine residues by using chemical modifiers such as the sulfhydryl reagent PCMBS and the histidine residue modifier DEPC. As shown in Fig. 7, pretreatment of rMATE1-expressing cells with PCMBS or DEPC led to a concentration-dependent decrease in the transport of [14C]TEA. The half-maximal inhibition for [14C]TEA transport via rMATE1 was calculated as 1.13 ± 0.91 mM for DEPC and 37.2 ± 10.2 µM for PCMBS.
|
|
pH Profile of TEA Uptake by rMATE1 H385Q. To investigate the role of the histidine residues, the pH profile of the uptake of [14C]TEA by the rMATE1 H385Q mutant was examined. When the extracellular pH was changed from 6.0 to 8.5, the transport of [14C]TEA by wild-type rMATE1 showed a bell-shaped curve with the greatest uptake value at pH 7.5. On the other hand, in the case of rMATE1 H385Q, no peak of the uptake was observed (Fig. 9).
|
| Discussion |
|---|
|
|
|---|
By mutational analysis, we found that Cys-62 and Cys-126 of rMATE1, which are located in the first and the third transmembrane domain, respectively, played critical roles in the transport activity of TEA (Figs. 1 and 2). It is interesting that the corresponding cysteine residues of hMATE1 and hMATE2-K also function as essential amino acid residues (Fig. 4), suggesting that these cysteine residues play critical roles in the MATE family. Furthermore, protection by the substrate against PCMBS-caused inhibition of the transport of TEA via rMATE1 (Fig. 8) suggested that cysteine residues of rMATE1 function as substrate-binding sites. Protection assay using rMATE1 C62G and C126G mutants suggested that both Cys-62 and Cys-126 are involved in the substrate binding, although we cannot rule out the possibility that other cysteine residues participated in the substrate recognition. Pelis et al. (2006
) have recently found that Cys-474 of hOCT2, which is suggested to be located in the 11th transmembrane helix that participates in the formation of the hydrophilic cleft, contributes to substrate-protein interaction. Because OCTs and MATEs have similar substrate specificity, although their driving forces are quite different, it is reasonable that the same amino acid cysteine is involved in the substrate recognition. The present results strongly suggest that Cys-62 and Cys-126 of rMATE1 play an important role for substrate-interaction sites.
Most of the His-385 mutants of rMATE1 (Figs. 2 and 3) and corresponding histidine mutants of hMATE1 and hMATE2-K (Fig. 4) did not have the TEA transport activity. Furthermore, the histidine modifier reagent DEPC also inhibited the transport of TEA via rMATE1 (Fig. 7). In contrast to the effect of PCMBS, the DEPC-caused inhibition of TEA transport was not blocked in the presence of excess TEA (Fig. 8), suggesting that histidine residue of rMATE1 does not serve as substrate-binding site. In other H+-coupled transporters such as H+/peptide cotransporter 1 (Uchiyama et al., 2003
) and Na+/H+ exchanger (Cha et al., 2003
), histidine residues function as an H+-binding site. It is, therefore, suggested that histidine residue of the MATE family acts as a H+-binding site for driving force.
The H+/organic cation antiport system is very sensitive to pH. The uptake of TEA was optimal at pH 7.0, and the uptake was markedly decreased at either an acidic or alkaline pH in renal brush-border membrane vesicle (Maegawa et al., 1988
). No peak in the uptake of TEA by the rMATE1 H385Q mutant was observed when the pH of the medium changed gradually (Fig. 9). His-385 of rMATE1 may be important to the bell-shaped transport activity and function not only in making the driving force but as a regulator of substrate transport. Further studies such as detailed kinetic analyses may be needed. To our knowledge, there has been no report that a histidine residue is involved in the transport of a substrate by the MATE family.
Site-directed mutagenesis revealed that Asp-32, Glu-251, and Asp-367 of NorM protein, which is a member of the Vibrio parahaemolyticus MATE family, are essential for the Na+-driven organic cation export (Otsuka et al., 2005b
). Mutated hMATE1 with Glu-273 replaced with glutamine, the counterpart of Glu-251 of NorM protein, lacked TEA transport activity (Otsuka et al., 2005a
). This glutamate residue is also conserved among rMATE1, mMATE1, and hMATE2-K. Previous studies using renal brush-border membrane vesicles treated with chemical modifiers revealed that carboxylate groups are critical for transport activity but are not involved in the substrate binding (Sokol et al., 1987
). Alternatively, it was speculated that carboxylate groups are responsible for H+ translocation process. It is therefore suggested that cysteine residues in the mammalian MATE family play a more important role for the substrate recognition than other amino acid residues. In MATE1, cysteine residues are located in the first and third transmembrane domains. The development of a three-dimensional model of MATE1 will clarify the molecular interaction of these amino acid residues with cationic substrates, as proposed for rat OCT1 (Popp et al., 2005
) and rabbit OCT2 (Zhang et al., 2005
).
In conclusion, we demonstrated that His-385, Cys-62, and Cys-126 in rMATE1 and corresponding amino acid residues of hMATE1 and hMATE2-K play an important role for the transport activity of MATE family. Cysteine residues of MATE1 make a key contribution to substrate recognition. This is the first study to identify the histidine and cysteine residues essential to the mammalian MATE family.
| Footnotes |
|---|
Article, publication date, and citation information can be found at http://molpharm.aspetjournals.org.
ABBREVIATIONS: MATE, multidrug and toxin extrusion; TEA, tetraethylammonium; DEPC, diethyl pyrocarbonate; PCMBS, p-chloromercuribenzenesulfonate; OCT, organic cation transporter; PAH, p-aminohippurate; TBS, Tris-buffered saline; HEK, human embryonic kidney.
The online version of this article (available at http://molpharm.aspetjournals.org) contains supplemental material. ![]()
Address correspondence to: Dr. Professor Ken-ichi Inui, Department of Pharmacy, Kyoto University Hospital, Sakyo-ku, Kyoto 606-8507, Japan. E-mail: inui{at}kuhp.kyoto-u.ac.jp
| References |
|---|
|
|
|---|
Cha B, Oh S, Shanmugaratnam J, Donowitz M, and Yun CC (2003) Two histidine residues in the juxta-membrane cytoplasmic domain of Na+/H+ exchanger isoform 3 (NHE3) determine the set point. J Membr Biol 191: 49–58.[CrossRef][Medline]
Goel M, Shinkins W, Keightley A, Kinter M, and Schilling WP (2005) Proteomic analysis of TRPC5- and TRPC6-binding partners reveals interaction with the plasmalemmal Na+/K+-ATPase. Pflueg Arch Eur J Physiol 451: 87–98.[CrossRef][Medline]
Hiasa M, Matsumoto T, Komatsu T, and Moriyama Y (2006) Wide variety of locations for rodent MATE1, a transporter protein that mediates the final excretion step for toxic organic cations. Am J Physiol 291: C678–C686.[CrossRef]
Hong M, Zhou M, and You G (2004) Critical amino acid residues in transmembrane domain 1 of the human organic anion transporter hOAT1. J Biol Chem 279: 31478–31482.
Hori R, Maegawa H, Kato M, Katsura T, and Inui K (1989) Inhibitory effect of diethyl pyrocarbonate on the H+/organic cation antiport system in rat renal brush-border membranes. J Biol Chem 264: 12232–12237.
Hori R, Maegawa H, Okano T, Takano M, and Inui K (1987) Effect of sulfhydryl reagents on tetraethylammonium transport in rat renal brush border membranes. J Pharmacol Exp Ther 241: 1010–1016.
Inui K, Masuda S, and Saito H (2000) Cellular and molecular aspects of drug transport in the kidney. Kidney Int 58: 944–958.[CrossRef][Medline]
Inui K and Okuda M (1998) Cellular and molecular mechanisms of renal tubular secretion of organic anions and cations. Clin Exp Nephrol 2: 100–108.[CrossRef]
Inui K, Saito H, and Hori R (1985) H+-gradient-dependent active transport of tetraethylammonium cation in apical-membrane vesicles isolated from kidney epithelial cell line LLC-PK1. Biochem J 227: 199–203.[Medline]
Maegawa H, Kato M, Inui K, and Hori R (1988) pH sensitivity of H+/organic cation antiport system in rat renal brush-border membranes. J Biol Chem 263: 11150–11154.
Masuda S, Terada T, Yonezawa A, Tanihara Y, Kishimoto K, Katsura T, Ogawa O, and Inui K (2006) Identification and functional characterization of a new human kidney-specific H+/organic cation antiporter, kidney-specific multidrug and toxin extrusion 2. J Am Soc Nephrol 17: 2127–2135.
Ohta K, Inoue K, Hayashi Y, and Yuasa H (2006) Molecular identification and functional characterization of rat MATE1 as an organic cation/H+ antiporter in the kidney. Drug Metab Dispos 34: 1868–1874.
Otsuka M, Matsumoto T, Morimoto R, Arioka S, Omote H, and Moriyama Y (2005a) A human transporter protein that mediates the final excretion step for toxic organic cations. Proc Natl Acad Sci USA 102: 17923–17928.
Otsuka M, Yasuda M, Morita Y, Otsuka C, Tsuchiya T, Omote H, and Moriyama Y (2005b) Identification of essential amino acid residues of the NorM Na+/multidrug antiporter in Vibrio parahaemolyticus. J Bacteriol 187: 1552–1558.
Pelis RM, Zhang X, Dangprapai Y, and Wright SH (2006) Cysteine accessibility in the hydrophilic cleft of the human organic cation transporter 2. J Biol Chem 281: 35272–35280.
Popp C, Gorboulev V, Muller TD, Gorbunov D, Shatskaya N, and Koepsell H (2005) Amino acids critical for substrate affinity of rat organic cation transporter 1 line the substrate binding region in a model derived from the tertiary structure of lactose permease. Mol Pharmacol 67: 1600–1611.
Saito H, Yamamoto M, Inui K, and Hori R (1992) Transcellular transport of organic cation across monolayers of kidney epithelial cell line LLC-PK1. Am J Physiol 262: C59–C66.[Medline]
Sokol PP, Holohan PD, and Ross CR (1987) N,N'-Dicyclohexylcarbodiimide inactivates organic cation transport in renal brush border membranes. J Pharmacol Exp Ther 243: 455–459.
Terada T, Masuda S, Asaka J, Tsuda M, Katsura T, and Inui K (2006) Molecular cloning, functional characterization and tissue distribution of rat H+/organic cation antiporter MATE1. Pharm Res (NY) 23: 1696–1701.
Terada T, Saito H, Mukai M, and Inui K (1996) Identification of the histidine residues involved in substrate recognition by a rat H+/peptide cotransporter, PEPT1. FEBS Lett 394: 196–200.[CrossRef][Medline]
Tsuda M, Terada T, Asaka J, Ueba M, Katsura T, and Inui K (2007) Oppositely-directed H+ gradient functions as a driving force of rat H+/organic cation antiporter MATE1. Am J Physiol 292: F593–F598.
Uchiyama T, Kulkarni AA, Davies DL, and Lee VH (2003) Biophysical evidence for His57 as a proton-binding site in the mammalian intestinal transporter hPepT1. Pharm Res (NY) 20: 1911–1916.
Urakami Y, Akazawa M, Saito H, Okuda M, and Inui K (2002) cDNA cloning, functional characterization, and tissue distribution of an alternatively spliced variant of organic cation transporter hOCT2 predominantly expressed in the human kidney. J Am Soc Nephrol 13: 1703–1710.
Wright SH (2005) Role of organic cation transporters in the renal handling of therapeutic agents and xenobiotics. Toxicol Appl Pharmacol 204: 309–319.[CrossRef][Medline]
Yonezawa A, Masuda S, Yokoo S, Katsura T, and Inui K (2006) Cisplatin and oxaliplatin, but not carboplatin and nedaplatin, are substrates for human organic cation transporters (SLC22A1–3 and MATE family). J Pharmacol Exp Ther 379: 879–886.
Zhang X, Shirahatti NV, Mahadevan D, and Wright SH (2005) A conserved glutamate residue in transmembrane helix 10 influences substrate specificity of rabbit OCT2 (SLC22A2). J Biol Chem 280: 34813–34822.
This article has been cited by other articles:
![]() |
T. Matsumoto, T. Kanamoto, M. Otsuka, H. Omote, and Y. Moriyama Role of glutamate residues in substrate recognition by human MATE1 polyspecific H+/organic cation exporter Am J Physiol Cell Physiol, April 1, 2008; 294(4): C1074 - C1078. [Abstract] [Full Text] [PDF] |
||||
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||